Sorry, I'm not having a dig. We all know biotech stocks are high...

  1. 2,257 Posts.
    lightbulb Created with Sketch. 409
    Sorry, I'm not having a dig. We all know biotech stocks are high risk, high reward. I don't think Invion is a basket case. Far from it. That's why I'm still keeping an eye on the stock and won't rule out buying back in. I'm not annoyed at the company. Ultimately, investing comes with risks and you live with the consequences. I am annoyed though with the manner Australian Small Cap Investigator handled this stock - a change in editor should not result in a 360 degree turnaround in sentiment from a ranging buy to a sell in a matter of weeks. I've said as much before. My comment about my doctor relatives was said tongue in cheek, so don't take it personally. Anyway, let's all hope July brings great results. p.s. doctors know lots more about drug development, etc than you think. I bought Sirtex on the recommendation of my haematologist brother in law when the stock was off the radar.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
10.0¢
Change
0.000(0.00%)
Mkt cap ! $8.541M
Open High Low Value Volume
10.0¢ 10.0¢ 10.0¢ $5K 50K

Buyers (Bids)

No. Vol. Price($)
1 75887 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 278228 3
View Market Depth
Last trade - 09.59am 31/07/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.